Impacts on product quality attributes of monoclonal antibodies produced in CHO cell bioreactor cultures during intentional mycoplasma contamination events-Reference-Cited by-同舟云学术

Impacts on product quality attributes of monoclonal antibodies produced in CHO cell bioreactor cultures during intentional mycoplasma contamination events

Published:2020-06-04 Issue:9 Volume:117 Page:2802-2815
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotechnology and Bioengineering

Author:

Fratz‐Berilla Erica J.¹^ORCID,Angart Phillip¹,Graham Ryan J.²³,Powers David N.¹^ORCID,Mohammad Adil²^ORCID,Kohnhorst Casey⁴,Faison Talia¹^ORCID,Velugula‐Yellela Sai Rashmika¹,Trunfio Nicholas⁵,Agarabi Cyrus¹^ORCID

Affiliation:

1. Division of Biotechnology Review and Research II, U.S. Food and Drug Administration Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Biotechnology Products Silver Spring Maryland

2. Division of Product Quality Research, U.S. Food and Drug Administration Center for Drug Evaluation and Research, Office of Pharmaceutical Quality, Office of Testing and Research Silver Spring Maryland

3. Department of Chemical Engineering University of Massachusetts Lowell Lowell Massachusetts

4. Nova Biomedical Waltham Massachusetts

5. Sartorius Stedim Data Analytics Bohemia New York

Funder

Oak Ridge Institute for Science and Education

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.27436

Reference37 articles.